Prophylactic intracameral vancomycin : efficacy in preventing endophthalmitis after cataract surgery

Background and objective: Post Operative endophthalmitis is rare but devastating complication in ocular surgery. The present study determined the efficacy of intracameral vancomycin after phaco-emusification cataract surgery to prevent endophthalmitis. Method: A total of 768 cases who had undergone phaco-emusification cataract surgery were included in the study. Every alternate patient received 0.5 ml injection of vancomycin (1mg in 0.1 ml) in the anterior chamber after completion of phaco-emulcification and formation of anterior chamber. All the patients were examined for symptoms and signs of bacterial endophthalmitis at 24 hrs, 7 days, 15 days and subsequently at 1, 3 and 6 months following surgery. Results: No endophthalmitis case was recorded at any time period during 6 month follow up in either group. However, significantly higher number of cases in vancomycin group had cells in anterior chamber and disturbances in visual acuity at day 15 following surgery. Conclusion: Vancomycin did not have any prophylactic role in preventing endophthalmitis. Proper aseptic measures are important to prevent any infection in ocular surgery. IMC J Med Sci 2016; 10(1): 24-28


Introduction
Intraocular infection following cataract surgery and lens implantation is a rare but dreadful complication that can have devastating consequences for sight.The Endophthalmitis Vitrectomy Study (EVS) estimated that up to half of patients developing endophthalmitis following cataract surgery had visual acuity worse than 20/40 and 15% had worse than 5/200 [1].The incidence of endophthalmitis following cataract surgery varies between 0.04 and 0.27% [2][3][4].Even though several risk factors have been identified, this complication is often unexpected, with variable response to standard treatment.The number of cataract surgeries is expected to rise with an increasing aging population in Bangladesh; the burden of endophthalmitis is likely to rise.A robust preventative strategy is needed to contain this serious complication.The European Society of Cataract and Refractive Surgeons (ESCRS) in a multinational, partially-masked placebo-controlled trial have provided strong evidence for using intracameral antibiotics in preventing postoperative endophthalmitis following cataract surgery [5].In this study, we determined the prophylactic effect of vancomycin injection in the anterior chamber at the end of phacoemulsification surgery in preventing post operative bacterial endophthalmitis.

Methods
A total of 768 cases undergoing phacoemulsification cataract surgery from January 2014 to December 2015 in the Department of Ophthalmology at BIRDEM general hospital were enrolled in the study.Every alternate eye (patient) received

Address for Correspondence:
Dr. Manash Kumar Goswami, Associate Professor, Department of Ophthalmology, BIRDEM General Hospital, 122 Kazi Nazrul Islam Avenue, Shahbag, Dhaka.Email: manashkg@yahoo.comintracameral injection of vancomycin (vancomycin group) while others did not receive any intracameral antibiotic and served as a control.The cases in control arm were treated according to the exiting protocol followed in the hospital for cataract surgery as described below.
In the anesthetic room, 10 minutes prior to cataract surgery, each patient had periocular skin cleaning with 5% povidone iodine.Two drops of 5% povidone iodine were instilled into the conjunctival sac at this stage.The surgeon, after scrubbing and draping, used 5% povidone iodine to cleanse the eyelids and periocular skin.The eyelids including the eye lashes were draped.All cataract surgeries were performed in a dedicated ophthalmic theatre assisted by resident doctor and ophthalmic specialist nurses.Phacoemulsification was performed using infiniti machine (Alcon).Every alternate patient got 0.5 ml injection of vancomycin (1mg in 0.1 ml) in the anterior chamber of the eye after completion of phaco-emulcification and formation of anterior chamber [5].Postoperatively, patients were prescribed prednisolone acetate 1% eye drop twohourly for two weeks which was then tapered off over a further four weeks.In addition, all cases received topical moxifloxacin eye drop two hourly for 1 week and 6 hourly for 2 weeks.All the patients were examined for symptoms and signs of bacterial endophthalmitis [4] at 24 hrs, 7days, and 15 days and subsequently at 1, 3 and 6 months following surgery.
The study was approved by the IRB of BADAS and informed written consent was obtained from each patient.

Results
A total of 768 cases were enrolled in the study of which 384 were in vancomycin group and 384 were in control group.The age range of the study population was 45-80 years.Male female distribution in vancomycin group was 283 and 101 respectively while in control group it was 237 and 147.All had type 2 diabetes mellitus of various durations.During the follow up, visual acuity, conjunctival congestion, cells in the anterior chamber and features of endophthalmitis were recorded.Table 1 shows the results of follow up at 24 hrs, 15 day and 6 month.Lost to follow up at day 15 and at 6 month were 44 and 23 cases in control group; 10 and 15 cases in vancomycin group respectively.No patients in any group developed features of bacterial endophthalmitis during this period.At 24 hrs, significantly higher proportion of cases had cells in anterior chamber in vancomycin group compared to control (22.3% vs 9.3%; p<0.05).Visual acuity was significantly (p<0.05)poor in vancomycin group (20.6%) compared to control (8.3%) at 15 day follow up.However, the visual acuity was similar in both groups at 6 month.In our study, we serially enrolled 384 patients undergoing phacoemulsification cataract surgery at BIRDEM general hospital over two year's period.Meticulous aseptic technique was followed in the operation theater.In the present series there was no single case of endophthalmitis in either group.However, cells in the anterior chamber immediately following surgery was significantly higher in vancomycin group compared to control who did not receive vancomycin.Similarly, the visual acuity was significantly poor in vancomycin group at 15 day follow up.But the visual acuity in vancomycin group gradually improved over time and was same as the control at 6 month.The reduced visual acuity observed among the patients in both group could be due to the presence of other co-morbid conditions like diabetes, aging, hypertension, etc.Though minimal, patient should be monitored if vancomycin is used as prophylactic antibiotic in cataract surgery.There was no adverse effect like cystoid macular edema in intracameral vancomycin group.Significant increase in incidence of cystoid macular edema has been reported with the use of intracameral vancomycin during extracapsular cataract extraction [20].It is interesting to note that no endophthalmitis has occurred in our cases who did not receive vancomycin as prophylaxis indicating that proper aseptic technique was adequate alone to prevent endophthalmitis and other infections following eye surgery.A recent survey on antibiotic prophylaxis practice after cataract surgery in the UK has reported that 37% of the respondents did not use intracameral antibiotic prophylaxis [21].
The present study demonstrated that proper pre and per operative aseptic measures together with the post operative use of standard topical antibiotics is adequate to prevent the bacterial endophthalmitis in cataract surgery.Routine use of prophylactic intracameral vancomycin did not have any additive value for the prevention of post operative bacterial endophthalmitis.

Table -
Note: A/C: anterior chamber; p<0.05 when compared between vancomycin and control group for visual acuity at day 15.
A, Newcomb RL, et al.